PPARA and metabolic dysfunction-associated steatotic liver disease: Additionally, in silico molecular docking analysis was conducted to identify active phytoconstituents within the extract and their interactions with key NAFLD‐related targets, including PPAR‐α, PPAR‐γ, AMPK, and SREBP‐1c.